Assessment of the rapid effect of dupilumab in two cases of severe asthma comorbid with recurrent eosinophilic chronic rhinosinusitis after endoscopic sinus surgery

Dupilumab, a human monoclonal antibody against interleukin‐4 (IL‐4) and IL‐13, has been approved for treating severe asthma and eosinophilic chronic rhinosinusitis (ECRS). Patients with ECRS are often candidates for endoscopic sinus surgery (ESS). However, a considerable number of patients have recu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kai, Yoshiro, Yoshikawa, Masanori, Matsuda, Masayuki, Fukuoka, Atsuhiko, Fujita, Yukio, Yamauchi, Motoo, Muro, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222642/
https://www.ncbi.nlm.nih.gov/pubmed/34194812
http://dx.doi.org/10.1002/rcr2.804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222642/
https://www.ncbi.nlm.nih.gov/pubmed/34194812
http://dx.doi.org/10.1002/rcr2.804

Ejemplares similares